Pages that link to "Q41086481"
Jump to navigation
Jump to search
The following pages link to Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac (Q41086481):
Displaying 30 items.
- Idiosyncratic adverse drug reactions: current concepts (Q26824391) (← links)
- Acute cholestatic hepatitis induced by nimesulide (Q28374375) (← links)
- Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites (Q28475945) (← links)
- Glucuronidation of drugs and drug-induced toxicity in humanized UDP-glucuronosyltransferase 1 mice (Q33742730) (← links)
- Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity (Q34088814) (← links)
- Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment (Q34122409) (← links)
- Metabolic activation in drug allergies. (Q34133689) (← links)
- Role of metabolism in drug-induced idiosyncratic hepatotoxicity (Q36179528) (← links)
- Role of intestinal cytochrome p450 enzymes in diclofenac-induced toxicity in the small intestine (Q36335498) (← links)
- The Role of Metabolic Activation in Drug Toxicity (Q40392352) (← links)
- Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology (Q40422942) (← links)
- Induction of hepatic heme oxygenase-1 by diclofenac in rodents: role of oxidative stress and cytochrome P-450 activity. (Q40645580) (← links)
- Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury (Q40817414) (← links)
- Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism (Q41172369) (← links)
- Covalent binding of xenobiotics to specific proteins in the liver (Q41501775) (← links)
- Hepatotoxicity in drug development: detection, significance and solutions (Q41515960) (← links)
- Diclofenac toxicity in human intestine ex vivo is not related to the formation of intestinal metabolites (Q42705851) (← links)
- Involvement of Lysosomal Labilisation and Lysosomal/mitochondrial Cross-Talk in Diclofenac Induced Hepatotoxicity (Q42927779) (← links)
- Nimesulide-induced acute hepatitis (Q43595644) (← links)
- Hepatic covalent adduct formation with zomepirac in the CD26-deficient mouse (Q43918476) (← links)
- Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity (Q44880285) (← links)
- Acyl-glucuronide as a Possible Cause of Trovafloxacin-Induced Liver Toxicity: Induction of Chemokine (C-X-C Motif) Ligand 2 by Trovafloxacin Acyl-glucuronide (Q47160583) (← links)
- Involvement of Reactive Metabolites of Diclofenac in Cytotoxicity in Sandwich-Cultured Rat Hepatocytes (Q50973715) (← links)
- Effects of dose, flow rate, and bile acid on diclofenac disposition in the perfused rat liver. (Q53618072) (← links)
- Model-based identification of TNFα-induced IKKβ-mediated and IκBα-mediated regulation of NFκB signal transduction as a tool to quantify the impact of drug-induced liver injury compounds. (Q55065406) (← links)
- The Role of Active Metabolites in Drug Toxicity (Q56474940) (← links)
- Drug metabolism and drug toxicity (Q57302790) (← links)
- Cytotoxic activity of T cells and non-T cells from diclofenac-immunized mice against cultured syngeneic hepatocytes exposed to diclofenac (Q71846432) (← links)
- Studies on the reactivity of acyl glucuronides--VIII. Generation of an antiserum for the detection of diflunisal-modified proteins in diflunisal-dosed rats (Q72494977) (← links)
- Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats (Q77620722) (← links)